首页> 美国卫生研究院文献>Clinical Orthopaedics and Related Research >Epithelioid Hemangioma of Bone and Soft Tissue: A Reappraisal of a Controversial Entity
【2h】

Epithelioid Hemangioma of Bone and Soft Tissue: A Reappraisal of a Controversial Entity

机译:骨和软组织的上皮样血管瘤:争议实体的重新评估。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe controversy surrounding diagnosis of an epithelioid hemangioma (EH), particularly when arising in skeletal locations, stems not only from its overlapping features with other malignant vascular neoplasms, but also from its somewhat aggressive clinical characteristics, including multifocal presentation and occasional lymph node involvement. Specifically, the distinction from epithelioid hemangioendothelioma (EHE) has been controversial. The recurrent t(1;3)(p36;q25) chromosomal translocation, resulting in WWTR1-CAMTA1 fusion, recently identified in EHE of various anatomic sites, but not in EH or other epithelioid vascular neoplasms, suggests distinct pathogeneses.
机译:背景技术关于上皮样血管瘤(EH)诊断的争议,尤其是在骨骼部位发生时,不仅源于其与其他恶性血管肿瘤的重叠特征,还源于其具有侵略性的临床特征,包括多灶性表现和偶尔的淋巴结受累。具体而言,与上皮样血管内皮瘤(EHE)的区别一直存在争议。复发性t(1; 3)(p36; q25)染色体易位,导致WWTR1-CAMTA1融合,最近在EHE的各种解剖部位中被发现,但在EH或其他上皮样血管肿瘤中却未发现,表明存在不同的病原体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号